Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ

Watchlist Manager
Eckert & Ziegler Strahlen und Medizintechnik AG Logo
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Watchlist
Price: 15.53 EUR -0.13%
Market Cap: 986.5m EUR

Eckert & Ziegler Strahlen und Medizintechnik AG
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Eckert & Ziegler Strahlen und Medizintechnik AG
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Free Cash Flow
€44.3m
CAGR 3-Years
N/A
CAGR 5-Years
16%
CAGR 10-Years
12%
Carl Zeiss Meditec AG
XETRA:AFX
Free Cash Flow
€83m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stratec SE
XETRA:SBS
Free Cash Flow
€3.2m
CAGR 3-Years
-44%
CAGR 5-Years
-8%
CAGR 10-Years
-20%
Siemens Healthineers AG
XETRA:SHL
Free Cash Flow
€2.7B
CAGR 3-Years
18%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Draegerwerk AG & Co KGaA
XETRA:DRW8
Free Cash Flow
€136.9m
CAGR 3-Years
N/A
CAGR 5-Years
8%
CAGR 10-Years
43%
Sartorius AG
XETRA:SRT
Free Cash Flow
€478.6m
CAGR 3-Years
43%
CAGR 5-Years
9%
CAGR 10-Years
26%
No Stocks Found

Eckert & Ziegler Strahlen und Medizintechnik AG
Glance View

Market Cap
971.8m EUR
Industry
Health Care

Eckert & Ziegler Strahlen- und Medizintechnik AG engages in the provision of isotope technology for medical, scientific, and industrial use. The company is headquartered in Berlin, Berlin and currently employs 866 full-time employees. The company went IPO on 2008-02-25. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

EUZ Intrinsic Value
HIDDEN
Show

See Also

What is Eckert & Ziegler Strahlen und Medizintechnik AG's Free Cash Flow?
Free Cash Flow
44.3m EUR

Based on the financial report for Sep 30, 2025, Eckert & Ziegler Strahlen und Medizintechnik AG's Free Cash Flow amounts to 44.3m EUR.

What is Eckert & Ziegler Strahlen und Medizintechnik AG's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
12%

Over the last year, the Free Cash Flow growth was 31%.

Back to Top